March 24, 2022
Open to all ISPOR Members and Non-members
- Elisabeth Fenwick
- Marjanne Piena
March 24, 2022
10:00AM EDT / 3:00PM GMT / 4:00PM CET
Click here for time zone conversion
In all stages of drug development, from discovery, evidence generation to support reimbursement & access, through to marketing and loss of exclusivity, data gaps are common and modeling is often a required element to help fill them. Creating bespoke modelling solutions to address these complex data gaps and challenges are required, with their outputs used to help navigate and inform stakeholders’ decision making. In this session, we will focus on novel modeling approaches used to plug these data gaps by presenting an application of the use of Pharmacometrics (PM) modelling in a Pharmacoeconomic (PE) evaluation in a post-marketing setting.
- Understand common data gaps in Health Economic (HE) analyses and the need for bespoke modeling solutions
- Consider an application of a PM model used for a PE analysis to fill a data gap relating to clinical outcomes
- Explore further methods and opportunities to navigate and fill data gaps for HE analyses in different stages of drug delivery
Sponsored by: OPEN Health
Elisabeth Fenwick, PhD, Senior Director Modeling & Meta-Analysis, OPEN Health, Oxford, United Kingdom
Marjanne Piena, MSc, Senior Research Consultant Modeling & Meta-Analysis, OPEN Health, Oxford, United Kingdom
Please note: On the day of the scheduled HEOR Theater, the first 1000 registered participants will be accepted. For those who are unable to attend, or would like to review the HEOR Theater On-Demand at a later date, please register using the link above to access the full-length recording.
Reservations are on a first-come, first-served basis.